ACTR087
ATTCK-17-01
Phase 1 mab terminated
Quick answer
ACTR087 for Multiple Myeloma is a Phase 1 program (mab) at Cogent Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cogent Biosciences
- Indication
- Multiple Myeloma
- Phase
- Phase 1
- Modality
- mab
- Status
- terminated